Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ivan Buzurovic, Ph.D.

Concepts (140)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brachytherapy28202312274.770 Why?
Radiotherapy, Computer-Assisted52013901.610 Why?
Film Dosimetry42020301.550 Why?
Radiotherapy Planning, Computer-Assisted17202316801.330 Why?
Radiotherapy Dosage19202329251.110 Why?
Robotics620138261.060 Why?
Needles520224550.890 Why?
Radiometry920208160.880 Why?
Catheters520234270.760 Why?
Radiotherapy, Conformal220135490.620 Why?
Genital Neoplasms, Female120235390.570 Why?
Uterine Cervical Neoplasms4202120400.490 Why?
Transistors, Electronic12013230.430 Why?
Telemetry120132000.380 Why?
Endometrial Neoplasms4202213820.370 Why?
Skin Diseases1202010990.370 Why?
Beds12011480.360 Why?
Prostatic Neoplasms112021112060.340 Why?
Movement3201214890.300 Why?
Patient Positioning120113320.300 Why?
Phantoms, Imaging4202225280.280 Why?
Prostheses and Implants1201312790.260 Why?
Radiation Oncology220235730.240 Why?
Equipment Failure Analysis320138480.220 Why?
Equipment Design4202135300.220 Why?
Calibration320208230.200 Why?
Vaginal Neoplasms120211050.180 Why?
Feasibility Studies2202153080.150 Why?
Dose-Response Relationship, Radiation220178820.150 Why?
DNA Mismatch Repair120214330.150 Why?
Automation120205880.140 Why?
Carcinoma, Endometrioid120192760.140 Why?
Carcinoma, Adenosquamous12016660.130 Why?
Software Validation12014590.120 Why?
Neoplasms32017223860.120 Why?
Carcinoma, Basal Cell120195640.110 Why?
Photons220155950.110 Why?
Carcinoma, Squamous Cell2201940830.100 Why?
Monte Carlo Method2201712620.100 Why?
Androgen Antagonists2201714180.100 Why?
Pennsylvania120136160.100 Why?
Catheters, Indwelling120144360.090 Why?
Swine1202159960.090 Why?
Mechanical Phenomena120121430.090 Why?
Magnetic Resonance Spectroscopy1202137830.090 Why?
Models, Theoretical2201735900.090 Why?
Radiotherapy1201715100.090 Why?
Skin Neoplasms3201958910.090 Why?
Humans2920237684510.090 Why?
Computer Systems120124700.090 Why?
Reproducibility of Results62015202310.090 Why?
Neoplasm Recurrence, Local5202294250.080 Why?
Ultrasonography2201459950.080 Why?
Tomography, X-Ray Computed42021207620.080 Why?
Linear Models1201958800.080 Why?
Academic Medical Centers2201627850.080 Why?
Prostate4202117810.080 Why?
Uterine Neoplasms1201714220.080 Why?
Magnetic Resonance Imaging32023368400.080 Why?
Evidence-Based Medicine1201937080.070 Why?
Dose-Response Relationship, Drug12019107840.070 Why?
Sensitivity and Specificity22013147280.070 Why?
Quality Assurance, Health Care2201521790.070 Why?
Lung Neoplasms12011135890.070 Why?
Radiotherapy, Intensity-Modulated120128110.060 Why?
Utilization Review220163840.060 Why?
Radiotherapy, Adjuvant2202017940.060 Why?
Female1120233969430.060 Why?
Health Physics12023370.050 Why?
Survival Analysis32021101250.050 Why?
Societies120231070.050 Why?
Prosthesis Implantation120075950.050 Why?
Retrospective Studies92022818340.050 Why?
Chemotherapy, Adjuvant2202035500.040 Why?
Carcinosarcoma120201080.040 Why?
Surgery, Computer-Assisted1200710050.040 Why?
Adenocarcinoma1201664000.040 Why?
Image Interpretation, Computer-Assisted1201234080.040 Why?
Adenocarcinoma, Clear Cell120202190.040 Why?
Male1120213647810.040 Why?
Research Report120203690.040 Why?
Prospective Studies12021549140.030 Why?
Time Factors32016402710.030 Why?
Algorithms22021141580.030 Why?
Colon, Sigmoid120171240.030 Why?
Patient Selection2201942660.030 Why?
Societies, Medical2201939550.030 Why?
Internship and Residency1201659520.030 Why?
Biopsy, Needle1202116290.030 Why?
Cystadenocarcinoma, Serous120204800.030 Why?
Neoplasm Staging22021112490.030 Why?
Combined Modality Therapy2201785590.030 Why?
Salvage Therapy1202212770.030 Why?
Aged820211715200.030 Why?
Antineoplastic Agents12017137080.030 Why?
Organs at Risk120173680.030 Why?
Color120152970.030 Why?
Aged, 80 and over42021596800.030 Why?
Scattering, Radiation120154910.030 Why?
Treatment Outcome52020654090.030 Why?
Particle Accelerators120131750.030 Why?
Materials Testing120158710.020 Why?
Rectum120179020.020 Why?
SEER Program1201714760.020 Why?
Middle Aged720212234180.020 Why?
United States42023731210.020 Why?
Water1201714210.020 Why?
Uncertainty120157580.020 Why?
Canada1201621430.020 Why?
Urinary Bladder1201711600.020 Why?
Tumor Burden1201619090.020 Why?
Watchful Waiting120144960.020 Why?
Light1201513570.020 Why?
Propensity Score1201719710.020 Why?
Animals120211694180.020 Why?
Biopsy1202168160.020 Why?
Temperature1201522370.020 Why?
Radiation Dosage1201719730.020 Why?
Cone-Beam Computed Tomography120124580.020 Why?
Probability1201324830.020 Why?
Antineoplastic Combined Chemotherapy Protocols22020118430.020 Why?
Adult520212235420.020 Why?
Micromanipulation12007530.020 Why?
Prostate-Specific Antigen1201624830.020 Why?
Disease-Free Survival1201668560.020 Why?
Survival Rate12020128750.020 Why?
Kaplan-Meier Estimate1201665370.020 Why?
Medical Oncology1201723470.020 Why?
Ultrasonography, Interventional1201415190.020 Why?
Databases, Factual1201780810.010 Why?
Models, Statistical1201551030.010 Why?
Cohort Studies12020417970.010 Why?
Imaging, Three-Dimensional1201140770.010 Why?
Prognosis12017300280.010 Why?
Computer Simulation1200762780.010 Why?
Breast Neoplasms12017211560.010 Why?
Young Adult12016600450.010 Why?
Adolescent12016891680.000 Why?
Risk Assessment12007243110.000 Why?
Risk Factors12007749150.000 Why?
Buzurovic's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (36)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.